Hjem › Burkitts lymfom › Michigan › Ann Arbor
Kliniske studier for Burkitts lymfom i Ann Arbor, MI
8 studier for Burkitts lymfom søker deltakere på steder i og rundt Ann Arbor (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- C S Mott Children's Hospital, Ann Arbor
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekruttererFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi unna
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
- og 4 flere
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RekruttererFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi unna
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
- og 4 flere
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- C S Mott Children's Hospital, Ann Arbor
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- C S Mott Children's Hospital, Ann Arbor
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- C S Mott Children's Hospital, Ann Arbor
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruttererFase 2
- C.S. Mott University of Michigan, Ann Arbor
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
RekruttererFase 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Burkitts lymfom-studier i andre byer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Milwaukee, WI16 studier
- Chicago, IL15 studier
- Cincinnati, OH13 studier
- New York City, NY13 studier
- Atlanta, GA12 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Kansas City, MO10 studier
Andre studier i Ann Arbor
- Brystkreft27 studier
- Prostatakreft27 studier
- Ikke-småcellet lungekreft26 studier
- Kreft (alle typer)25 studier
- Lungekreft23 studier
- Kolorektal kreft23 studier
- Hjertesvikt22 studier
- Akut myelogen leukemi17 studier
- Kardiovaskulær sykdom16 studier
- Pankreaskreft14 studier
- Melanom12 studier
- Slag12 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.